A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2013
12/19/2013	US20130336919 Compounds and methods for inhibiting phosphate transport
12/19/2013	US20130336918 Compounds and methods for inhibiting phosphate transport
12/19/2013	US20130336899 Antimicrobial formulations that aid in wound healing
12/19/2013	US20130336898 Process for preparing a pharmaceutical formulation of contrast agents
12/19/2013	US20130336893 Exedin-4 Peptide Analogues
12/19/2013	US20130336886 Tumor specific antibodies and uses therefor
12/19/2013	DE112012001382T5 Arzneimittelfreie Zusammensetzungen und Methoden zur Verminderung von peripheren Entzündungen und Schmerzen Drug-free compositions and methods for the reduction of peripheral inflammation and pain
12/19/2013	DE102010064538A1 Treating ankylosing spondylitis (Bechterew's or Marie-strumpel inflammatory disease), which is a genetic disposition disease and affects iliosacral joints, vertebral column and large joints of lower limbs
12/19/2013	CA2876177A1 Treatment and prevention of cardiovascular disease and thrombosis
12/18/2013	EP2674164A1 Kallikrein inhibitors and uses thereof
12/18/2013	EP2674160A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
12/18/2013	EP2674157A1 Therapeutic agent for diastolic congestive heart failure
12/18/2013	EP2674156A1 Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants thereof and other members of the erbb/her family
12/18/2013	EP2672999A2 Improved immunotherapy
12/18/2013	EP2672969A1 Combination
12/18/2013	EP2265263B1 Chewing composition and the use thereof
12/18/2013	EP2254570B1 Combination comprising paclitaxel for treating ovarian cancer
12/18/2013	EP2165715B1 Therapeutic agent for cancer, and method for treatment of cancer
12/18/2013	EP2020237B1 Ceramide and chemotherapeutic agents for inducing cell death
12/18/2013	EP1982710B1 Composition for prevention of recurrence of stroke
12/18/2013	EP1932541B1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent
12/18/2013	EP1782800B1 Methods for detecting JAK3 inhibitors
12/18/2013	CN103458910A Hot flash suppressant
12/18/2013	CN103458893A Sn-1(3) monoacylglycerides and lipid absorption
12/18/2013	CN103458887A Nutritional compositions for increasing arginine levels and methods of using same
12/18/2013	CN103446587A Application of mastocyte inhibitor in preparation of medicine for resisting influenza virus infection
12/18/2013	CN102871953B Super-absorbent adsorption suppository
12/18/2013	CN102335435B Multifunctional polyurethane medicament carrier as well as preparation method and application thereof
12/18/2013	CN102105151B Use of CDK inhibitor for treatment of glioma
12/17/2013	US8609702 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use
12/17/2013	US8609695 Methods of treating and/or suppressing insulin resistance
12/17/2013	US8609616 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
12/17/2013	CA2782498C Tablet composition containing kampo medicinal extract and its manufacturing process
12/17/2013	CA2659774C Use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas
12/17/2013	CA2620554C Treatment of autoimmune diseases
12/17/2013	CA2538064C Antibiotic product, use and formulation thereof
12/17/2013	CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia
12/17/2013	CA2498378C Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
12/17/2013	CA2478997C Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure
12/17/2013	CA2478855C Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
12/17/2013	CA2427310C Imaging, diagnosis and treatment of angiogenesis-related diseases comprising ecsm4
12/12/2013	WO2013184960A2 Chimeric fibroblast growth factor 23 proteins and methods of use
12/12/2013	WO2013184527A1 Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
12/12/2013	WO2013182933A1 Use of ghrelin receptor inverse agonists or antagonists for treating sleep disorders
12/12/2013	WO2013182668A1 Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
12/12/2013	WO2013182519A1 Combination of lysosomotropic or autophagy modulating agents and a gsk-3 inhibitor for treatment of cancer
12/12/2013	WO2013182485A1 Clay mineral for reducing inorganic phosphates, in particular in renal replacement therapy
12/12/2013	WO2012143787A8 Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity
12/12/2013	US20130331769 Methods for treating headaches
12/12/2013	US20130331460 Chrysophaentin analogs that inhibit ftsz protein
12/12/2013	US20130331457 Treatment of cancer
12/12/2013	US20130331452 Benzoic acid compounds for reducing uric acid
12/12/2013	US20130331447 Methods of treating hypertriglyceridemia
12/12/2013	US20130331446 3-acyl-ingenols ii
12/12/2013	US20130331440 Ucp1 (thermogenin) - inducing agents for use in the treatment of a disorder of the energy homeostasis
12/12/2013	US20130331432 Metabolic gene, enzyme, and flux targets for cancer therapy
12/12/2013	US20130331422 Methods and devices for using isoperilly alcohol
12/12/2013	US20130331419 Mineralocorticoid receptor antagonists
12/12/2013	US20130331416 Dosage regimen for comt inhibitors
12/12/2013	US20130331414 Inhibitors of Retroviral Replication
12/12/2013	US20130331408 Opioid Receptor Ligands and Methods of Using and Making Same
12/12/2013	US20130331404 Methods and Compositions for Inhibition of Polymerase
12/12/2013	US20130331394 Treating schizophrenia
12/12/2013	US20130331387 Heteroaryl derivatives as alpha7 nachr modulators
12/12/2013	US20130331386 Methods for treating vascular leak syndrome
12/12/2013	US20130331385 Compositions and methods for treating ophthalmic, otic, or nasal infections
12/12/2013	US20130331384 Firmocidin, an antimicrobial molecule produced by staphylococcus epidermidis
12/12/2013	US20130331383 Nitrofuran compounds for the treatment of cancer and angiogenesis
12/12/2013	US20130331382 Pyridinone and Pyridazinone Derivatives
12/12/2013	US20130331373 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
12/12/2013	US20130331372 Cyclic Amine Substituted Oxazolidinone CETP Inhibitor
12/12/2013	US20130331369 3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists
12/12/2013	US20130331364 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/12/2013	US20130331363 Organic compounds
12/12/2013	US20130331361 Dosage forms of bisphosphonates
12/12/2013	US20130331355 Cyclic boronic acid ester derivatives and therapeutic uses thereof
12/12/2013	US20130331349 Compositions and methods for modulating fxr
12/12/2013	US20130331328 Small molecule inhibitors of agbl2
12/12/2013	US20130331325 Chimeric fibroblast growth factor 23 proteins and methods of use
12/12/2013	US20130331322 Exendins and exendin agonist analogs to regulate gastrointestinal motility
12/12/2013	US20130331321 Perhexiline for treating chronic heart failure
12/12/2013	US20130331317 Chimeric fibroblast growth factor 19 proteins and methods of use
12/12/2013	US20130331316 Chimeric fibroblast growth factor 21 proteins and methods of use
12/12/2013	US20130331313 Methods and compositions for treating viral or virally-induced conditions
12/12/2013	US20130330423 Composition to increase joint and/or postural stability
12/12/2013	US20130330422 Methods for increasing insulin sensitivity and treating diabetes with a bioactive chromium binding peptide
12/12/2013	US20130330412 Smart polymeric nanoparticles which overcome multidrug resistance to cancer therapeutics and treatment-related systemic toxicity
12/12/2013	US20130330411 Pharmaceutical cyclosporin compositions
12/12/2013	US20130330403 Diagnosis And Treatment Of Cancers With MicroRNA Located In Or Near Cancer-Associated Chromosomal Features
12/12/2013	US20130330397 Wound Care Products with Peracid Compositions
12/12/2013	US20130330377 C-Met Modulator Pharmaceutical Compositions
12/12/2013	US20130330372 Formulations Comprising Extracts From Primitive Plant Species (Mosses, Ferns and Lichens) to Treat and Prevent Cancers
12/12/2013	US20130330366 Neprilysin inhibitors
12/12/2013	US20130330365 Neprilysin inhibitors
12/12/2013	US20130330364 Therapeutic formulations
12/12/2013	US20130330352 Treatment of myocardial infarction using tgf beta antagonists
12/12/2013	US20130330344 Antibody molecules having specificity for human ox40
12/12/2013	US20130330332 Treatment of pemphigus
12/12/2013	US20130330324 Antibodies for epidermal growth factor receptor 3 (her3)
12/12/2013	US20130330318 Method for Treating Filtration Failure After Trabeculectomy Surgery

1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 1151